Pediatric Nonrhabdomyosarcoma Soft Tissue Sarcomas
Authors:
Open Access
- 1 June 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 13 (6) , 668-678
Abstract
Learning Objectives: After completing this course, the reader will be able to: Evaluate the clinical features of NRSTS in pediatric patients.Identify the factors that influence the selection of treatment and the clinical outcomes of pediatric patients with NRSTS.Select an appropriate treatment strategy for pediatric patients with NRSTS. CME This article is available for continuing medical education credit at CME.TheOncologist.com The nonrhabdomyosarcoma soft tissue sarcomas (NRSTSs) are a heterogeneous group of mesenchymal cell neoplasms that account for about 4% of childhood cancers. Because each histologic subtype of NRSTS is rare, they have been poorly studied and little is known about their biology, natural history, or optimal treatment. Data from adults with soft tissue sarcomas provide some helpful insight, but adult and childhood NRSTSs differ considerably in the distribution of their histologic subtypes, and certain entities are known to behave differently in young children. The greater risks posed to children by treatment, particularly by radiotherapy, also must be considered in treatment planning for children. This article summarizes what is known to date about childhood NRSTS, including the epidemiology, pathogenesis, and clinical approach to diagnosis and treatment of these tumors.Keywords
Funding Information
- National Cancer Institute
This publication has 98 references indexed in Scilit:
- Randomized Phase II Study of Gemcitabine and Docetaxel Compared With Gemcitabine Alone in Patients With Metastatic Soft Tissue Sarcomas: Results of Sarcoma Alliance for Research Through Collaboration Study 002Journal of Clinical Oncology, 2007
- Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancersNature, 2007
- Ecteinascidin‐743: Evidence of Activity in Advanced, Pretreated Soft Tissue and Bone Sarcoma PatientsSarcoma, 2006
- Constitutive Hedgehog Signaling in Chondrosarcoma Up-Regulates Tumor Cell ProliferationThe American Journal of Pathology, 2006
- Prospective longitudinal evaluation of doxorubicin‐induced cardiomyopathy in sarcoma patients: A report of the late effects surveillance system (LESS)Pediatric Blood & Cancer, 2005
- Hsp90 Inhibitor 17-Allylamino-17-Demethoxygeldanamycin Prevents Synovial Sarcoma Proliferation via Apoptosis in In vitro ModelsClinical Cancer Research, 2005
- Adult-Type Soft Tissue Sarcomas in Pediatric-Age Patients: Experience at the Istituto Nazionale Tumori in MilanJournal of Clinical Oncology, 2005
- Molecular Prognostication for Soft Tissue Sarcomas: Are We Ready Yet?Journal of Clinical Oncology, 2004
- The Hallmarks of CancerCell, 2000
- Long-Term Follow-up of von Recklinghausen NeurofibromatosisNew England Journal of Medicine, 1986